GO:0038146 chemokine (C-X-C motif) ligand 12 signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038146 describes the molecular signaling cascade triggered when the chemokine CXCL12 binds its receptors CXCR4 or CXCR7 on the target cell surface, culminating in regulation of downstream cellular processes such as transcription.
• CXCL12 (also known as SDF-1) is a homeostatic chemokine that controls cell migration, survival, proliferation, and differentiation in development, immunity, and tissue repair.
• The CXCL12-CXCR4/CXCR7 axis is a major driver of tumor progression, metastasis, angiogenesis, and immunosuppression in multiple cancers.
• Dysregulated CXCL12 signaling contributes to fibrosis, where it promotes fibroblast recruitment and extracellular matrix deposition.
• In the nervous system, CXCL12/CXCR4 signaling modulates neuronal autophagy and survival under oxygen-glucose deprivation/reoxygenation stress.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models are essential tools for dissecting causal roles of CXCL12 pathway components in disease.
Description
The chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146) is a biological process defined as the series of molecular signals initiated by binding of the chemokine CXCL12 to its receptor on the surface of a target cell, ending with regulation of a downstream cellular process such as transcription. CXCL12, historically named stromal cell-derived factor-1 (SDF-1), is a homeostatic chemokine that signals primarily through the G-protein-coupled receptors CXCR4 and CXCR7. This pathway is evolutionarily conserved and essential for organogenesis, hematopoiesis, immune cell trafficking, and tissue repair. Because it orchestrates cell migration, survival, proliferation, and gene expression, the CXCL12 signaling axis is a central node in both normal physiology and numerous pathological conditions.
chemokine (C-X-C motif) ligand 12 signaling pathway At A Glance
| GO ID | GO:0038146 |
|---|---|
| GO term | chemokine (C-X-C motif) ligand 12 signaling pathway |
| Ontology | biological_process |
| Synonym | CXCL12 signaling pathway; SDF1 signaling pathway; stromal cell-derived factor-1 signaling pathway; CXCL12-activated CXCR7 signaling pathway |
| Major function | Transduces CXCL12 binding to CXCR4/CXCR7 into intracellular signals that regulate chemotaxis, survival, proliferation, and transcription |
| Ligand | CXCL12 (SDF-1) |
| Receptors | CXCR4 (G-protein-coupled receptor) and CXCR7 (atypical chemokine receptor) |
| Downstream effectors | G-protein subunits, PI3K/AKT, MAPK/ERK, JAK/STAT, and transcriptional regulators |
| Disease relevance | Cancer metastasis, fibrosis, neuroinflammation, and hematopoietic disorders |
What Is GO:0038146?
GO:0038146 (chemokine (C-X-C motif) ligand 12 signaling pathway) is the series of molecular signals initiated by the binding of the chemokine CXCL12 to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. The term encompasses signaling through CXCR4 and CXCR7 and includes the downstream intracellular cascades that convert receptor engagement into changes in cell behavior or gene expression.
Why Is chemokine (C-X-C motif) ligand 12 signaling pathway Important in Cell Biology?
The CXCL12 signaling pathway is critically important because it governs fundamental processes such as cell migration, survival, and gene expression, and its dysregulation is implicated in cancer, fibrosis, and neurological disorders. Understanding this pathway at molecular resolution enables researchers to identify therapeutic targets and to design experiments that test causality using gene-editing approaches.
• Controls directed cell migration (chemotaxis) in development and immunity.
• Promotes tumor cell proliferation, survival, and metastatic dissemination in breast, gastric, and liver cancers.
• Drives angiogenesis and immunosuppression in the tumor microenvironment.
• Mediates fibroblast recruitment and extracellular matrix deposition in fibrosis.
• Regulates neuronal autophagy and survival under ischemic stress.
• Supports hematopoietic stem cell maintenance and megakaryocytopoiesis.
• Serves as a target for pharmacological intervention in cancer and inflammatory diseases.
• Provides a model for studying GPCR signaling and biased agonism.
• Enables CRISPR-based dissection of ligand-receptor interactions and downstream effectors.
• Links chemokine biology to transcriptional regulation via SOX18 and PD-L1 in cancer.
What Happens During chemokine (C-X-C motif) ligand 12 signaling pathway?
CXCL12 binding to CXCR4 and CXCR7
In simple terms: CXCL12 acts like a key that fits two different locks on the cell surface, CXCR4 and CXCR7.
The pathway begins when the chemokine CXCL12 binds with high affinity to its cognate receptors CXCR4 and CXCR7 on the target cell membrane. CXCR4 is a classical G-protein-coupled receptor (GPCR) that mediates most of the canonical signaling, while CXCR7 is an atypical chemokine receptor that can also bind CXCL12 and modulate its availability and signaling. This binding event is the initiating step of GO:0038146 and determines the specificity of downstream responses.
G-protein activation and second messenger generation
In simple terms: Once CXCL12 binds CXCR4, the receptor activates G-proteins inside the cell, which then trigger multiple signaling cascades.
Ligand-bound CXCR4 activates heterotrimeric G-proteins, leading to dissociation of Gα and Gβγ subunits. This activation results in inhibition of adenylyl cyclase, generation of inositol trisphosphate and diacylglycerol, and mobilization of intracellular calcium. These second messengers propagate the signal to downstream kinases and adaptor proteins.
Activation of PI3K/AKT, MAPK/ERK, and JAK/STAT cascades
In simple terms: The signal branches into several intracellular highways that control survival, growth, and gene expression.
CXCL12-CXCR4 signaling activates the PI3K/AKT pathway, which promotes cell survival and proliferation, and the MAPK/ERK cascade, which regulates gene expression and cell cycle progression. Additionally, JAK/STAT signaling can be engaged, contributing to transcriptional changes. These pathways collectively mediate the diverse biological outputs of CXCL12, including chemotaxis, survival, and proliferation.
Transcriptional regulation and downstream cellular responses
In simple terms: The signal ultimately reaches the nucleus, where it switches genes on or off, changing what the cell does.
Activated signaling cascades lead to phosphorylation and activation of transcription factors such as NF-κB, STATs, and others, resulting in altered gene expression. For example, TGF-β1-induced SOX18 transcriptionally upregulates PD-L1 and CXCL12 in hepatocellular carcinoma, linking CXCL12 signaling to immune evasion. The pathway ends with regulation of downstream cellular processes, including transcription, as defined in GO:0038146.
Modulation by CXCR7 and receptor trafficking
In simple terms: CXCR7 acts as a decoy or modulator that can fine-tune how much signal gets through.
CXCR7 binds CXCL12 but does not activate classical G-protein signaling; instead, it can sequester the ligand, internalize it, and modulate CXCR4-mediated responses. This interplay between CXCR4 and CXCR7 adds a layer of regulation to the pathway and influences outcomes such as cell migration and survival.
Key Genes Involved in GO:0038146 chemokine (C-X-C motif) ligand 12 signaling pathway
The following genes and proteins are core components or modulators of the CXCL12 signaling pathway (GO:0038146).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL12 | Ligand that initiates the pathway by binding CXCR4/CXCR7 | Knockout or overexpression models to study chemotaxis and metastasis |
| CXCR4 | Primary G-protein-coupled receptor mediating CXCL12 signaling | Knockout and point-mutation models to dissect downstream signaling |
| CXCR7 | Atypical receptor that modulates CXCL12 availability and signaling | Knockout models to study ligand sequestration and biased signaling |
| GNAI1 | G-protein alpha subunit that inhibits adenylyl cyclase downstream of CXCR4 | Knockout to block G-protein-mediated signaling |
| PIK3CA | Catalytic subunit of PI3K, activates AKT survival signaling | Overexpression or point mutation to study survival and proliferation |
| AKT1 | Serine/threonine kinase promoting cell survival and growth | Knockout or knock-in of activating mutations to assess downstream effects |
| MAPK1 | ERK2 kinase that transduces signals to transcription factors | Knockout to study gene expression changes |
| STAT3 | Transcription factor activated by JAK/STAT signaling | Knockout or point mutation to study transcriptional regulation |
| SOX18 | Transcription factor that upregulates PD-L1 and CXCL12 in hepatocellular carcinoma | Knockout or overexpression to study immune evasion |
| PD-L1 | Immune checkpoint protein upregulated by SOX18 and linked to CXCL12 signaling | Knock-in reporters to monitor expression |
| PIT1 | Transcription factor that promotes CXCL12 expression in breast cancer metastasis | Knockout to reduce metastasis |
| TGFB1 | Cytokine that induces SOX18 and CXCL12 expression | Overexpression or knockout to study fibrosis and cancer |
| TPO | Thrombopoietin, involved in megakaryocytopoiesis with CXCL12 | Knockout models to study hematopoietic differentiation |
| CXCR4 (neuronal) | Mediates CXCL12 effects on neuronal autophagy under OGD/R | Knockout or knockdown in SH-SY5Y cells to study autophagy |
| NFKB1 | Transcription factor activated downstream of CXCL12 signaling | Knockout to study inflammatory gene expression |
| JAK2 | Kinase that phosphorylates STATs downstream of CXCR4 | Point mutation to block kinase activity |
| ARRB1 | Beta-arrestin that regulates CXCR4 internalization and signaling | Knockout to study receptor trafficking |
| MMP9 | Matrix metalloproteinase induced by CXCL12 signaling, promotes invasion | Knockout to reduce metastasis in models |
How Is chemokine (C-X-C motif) ligand 12 signaling pathway Regulated?
The CXCL12 signaling pathway is regulated at multiple levels. Receptor availability is controlled by CXCR7-mediated sequestration and internalization of CXCL12. Beta-arrestin recruitment to CXCR4 promotes receptor desensitization and internalization, thereby limiting signal duration. Transcriptional regulation of CXCL12 itself is influenced by factors such as TGF-β1-induced SOX18 and Pit-1, which upregulate CXCL12 expression in cancer cells. Additionally, post-translational modifications of signaling intermediates, including phosphorylation of AKT and MAPK, fine-tune pathway output.
chemokine (C-X-C motif) ligand 12 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL12 | Breast cancer metastasis to liver and lung | Knockout or overexpression in breast cancer cell lines and mouse models |
| CXCR4 | Tumor progression and fibrosis | Knockout mice or CRISPR knockout cell lines |
| SOX18 | Hepatocellular carcinoma progression and immune evasion | Knockout or overexpression in HCC cell lines |
| CXCR4 (neuronal) | Ischemic neuronal injury and autophagy | SH-SY5Y cells with OGD/R and CXCR4 knockdown |
| CXCL12/CXCR4 | Gastric cancer angiogenesis and immunosuppression | Cancer-associated fibroblast co-culture models |
Cancer progression and metastasis
The CXCL12-CXCR4/CXCR7 axis is a major driver of tumor progression, promoting proliferation, angiogenesis, metastasis, and immunosuppression. In breast cancer, the Pit-1-CXCL12-CXCR4 axis facilitates metastasis to liver and lung. In hepatocellular carcinoma, TGF-β1-induced SOX18 transcriptionally upregulates PD-L1 and CXCL12, contributing to immune evasion and metastasis. Cancer-associated fibroblasts in gastric cancer promote proliferation, angiogenesis, metastasis, and immunosuppression via CXCL12 signaling.
Fibrosis
CXCL12/CXCR4 signaling is critically involved in the pathogenesis of fibrosis by recruiting fibroblasts and promoting extracellular matrix deposition. Targeting this axis has been proposed as a therapeutic strategy to limit fibrotic remodeling in multiple organs.
Neurological disorders
In the nervous system, CXCL12/CXCR4 signaling regulates oxygen-glucose deprivation/reoxygenation-induced autophagy in SH-SY5Y neuronal cells, suggesting a role in ischemic brain injury and neurodegeneration.
Hematopoietic and immune disorders
CXCL12 signaling is essential for hematopoietic stem cell maintenance and megakaryocytopoiesis, and its dysregulation can contribute to hematological abnormalities. The pathway also controls immune cell trafficking, and its modulation is being explored for anti-inflammatory therapies.
From chemokine (C-X-C motif) ligand 12 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CXCL12 drive tumor metastasis? | CXCL12 knockout or overexpression in cancer cell lines and mouse xenografts |
| What is the role of CXCR4 G-protein signaling? | CXCR4 point mutations that uncouple G-protein binding |
| How does CXCR7 modulate CXCL12 availability? | CXCR7 knockout or knock-in reporter cell lines |
| Does SOX18 regulate CXCL12 and PD-L1 transcription? | SOX18 knockout or overexpression in hepatocellular carcinoma cells |
| How does CXCL12 affect neuronal autophagy? | CXCR4 knockdown in SH-SY5Y cells under OGD/R |
| Can CXCL12 signaling be targeted in fibrosis? | CXCR4 knockout fibroblasts or conditional knockout mice |
How to Study the chemokine (C-X-C motif) ligand 12 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptional changes | Identify CXCL12-regulated genes |
| Phosphoproteomics | Kinase activation and signaling dynamics | Map PI3K/AKT and MAPK/ERK activation |
| Transwell migration assay | Chemotaxis toward CXCL12 | Assess cell migration capacity |
| Live-cell imaging | Receptor internalization and trafficking | Study CXCR4/CXCR7 dynamics |
| CRISPR knockout screens | Gene essentiality and pathway regulators | Discover novel modulators of CXCL12 signaling |
| Western blot | Protein expression and phosphorylation | Validate signaling activation |
| ELISA | Cytokine secretion | Measure CXCL12 levels in conditioned media |
| Flow cytometry | Surface receptor expression | Quantify CXCR4/CXCR7 levels |
Transcriptomic analysis (RNA-seq)
RNA sequencing can identify global transcriptional changes downstream of CXCL12 signaling, revealing target genes regulated by transcription factors such as SOX18, NF-κB, and STAT3. This method is useful for defining the transcriptional output of GO:0038146 in different cell types.
Proteomic and phosphoproteomic profiling
Mass spectrometry-based proteomics can quantify phosphorylation events in PI3K/AKT, MAPK/ERK, and JAK/STAT pathways following CXCL12 stimulation, providing a systems-level view of signaling dynamics.
Live-cell imaging and chemotaxis assays
Time-lapse microscopy and transwell migration assays measure chemotaxis and receptor trafficking in response to CXCL12 gradients, directly assessing the functional output of the pathway.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of CXCL12 signaling and its downstream effects, such as genes required for metastasis or immune evasion.
How CRISPR Can Be Used to Study GO:0038146 chemokine (C-X-C motif) ligand 12 signaling pathway
Knockout
CRISPR knockout of CXCL12, CXCR4, or CXCR7 enables loss-of-function studies to determine their causal roles in cell migration, survival, and tumor progression. Knockout of downstream effectors such as AKT1 or STAT3 can dissect specific branches of the pathway.
Point Mutation
Point mutations can be introduced into CXCR4 to uncouple G-protein binding or to mimic phosphorylation sites, allowing precise interrogation of signaling mechanisms. Similarly, activating mutations in PIK3CA or AKT1 can be modeled to study their contribution to CXCL12-driven phenotypes.
Knock-in
Knock-in of fluorescent reporters (e.g., GFP) into the CXCL12 or CXCR4 locus allows real-time monitoring of expression and localization in living cells. Tagged knock-in of signaling proteins can facilitate proteomic and imaging studies.
Overexpression
Overexpression of CXCL12 or CXCR4 via CRISPR activation or lentiviral delivery can enhance pathway activity and model gain-of-function states observed in cancer. This approach is useful for studying the sufficiency of CXCL12 signaling in driving metastasis or immune evasion.
How EDITGENE Supports chemokine (C-X-C motif) ligand 12 signaling pathway Research
Researchers studying chemokine (C-X-C motif) ligand 12 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway output or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for chemokine (C-X-C motif) ligand 12 signaling pathway research.
Frequently Asked Questions About chemokine (C-X-C motif) ligand 12 signaling pathway
What is GO:0038146?
GO:0038146 is the Gene Ontology term for the chemokine (C-X-C motif) ligand 12 signaling pathway, defined as the series of molecular signals initiated by CXCL12 binding to its receptor on the target cell surface, ending with regulation of a downstream cellular process such as transcription.
What is the CXCL12 signaling pathway?
The CXCL12 signaling pathway is a biological process in which the chemokine CXCL12 (SDF-1) binds to CXCR4 or CXCR7, activating intracellular cascades that control cell migration, survival, proliferation, and gene expression.
What genes are involved in CXCL12 signaling?
Key genes include CXCL12, CXCR4, CXCR7, GNAI1, PIK3CA, AKT1, MAPK1, STAT3, SOX18, and PD-L1, among others.
What diseases are associated with CXCL12 signaling?
CXCL12 signaling is implicated in cancer metastasis, fibrosis, neurological disorders, and hematopoietic abnormalities.
How does CXCL12 bind to CXCR4?
CXCL12 binds the extracellular loops and N-terminus of CXCR4, a G-protein-coupled receptor, triggering conformational changes that activate heterotrimeric G-proteins.
What is the role of CXCR7 in CXCL12 signaling?
CXCR7 is an atypical chemokine receptor that binds CXCL12 and modulates its availability by sequestration and internalization, thereby fine-tuning CXCR4-mediated signaling.
How is CXCL12 signaling studied in the lab?
Common methods include RNA-seq, phosphoproteomics, chemotaxis assays, live-cell imaging, and CRISPR-based genetic screens.
Can CRISPR be used to study CXCL12 signaling?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect the causal roles of CXCL12 pathway components.
What is the role of CXCL12 in cancer?
CXCL12 promotes tumor cell proliferation, survival, angiogenesis, metastasis, and immunosuppression in multiple cancer types.
How does CXCL12 affect neurons?
CXCL12/CXCR4 signaling regulates oxygen-glucose deprivation/reoxygenation-induced autophagy in neuronal cells, suggesting a role in ischemic injury.
Conclusion
GO:0038146 (chemokine (C-X-C motif) ligand 12 signaling pathway) is a fundamental biological process that translates CXCL12 binding into diverse cellular responses, including migration, survival, and transcription. Its dysregulation is central to cancer, fibrosis, and neurological disorders, making it a high-priority target for mechanistic and therapeutic research. CRISPR-based models are indispensable for establishing causality and for developing targeted interventions.
References
- 1. Yang Y et al.. 2023. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications.. Int J Biol Sci 19(11):3341-3359 PMID: 37497001
- 2. Wu X et al.. 2023. CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis.. Ageing Res Rev 83:101809 PMID: 36442720
- 3. Chen J et al.. 2024. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.. Gastroenterology 167(2):264-280 PMID: 38417530
- 4. Cambier S et al.. 2023. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.. Cell Mol Immunol 20(3):217-251 PMID: 36725964
- 5. Li P et al.. 2024. Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer.. Matrix Biol 132:59-71 PMID: 38936680
- 6. Zheng C et al.. 2008. TPO-independent megakaryocytopoiesis.. Crit Rev Oncol Hematol 65(3):212-22 PMID: 18093840
- 7. Martinez-Ordoñez A et al.. 2018. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.. Oncogene 37(11):1430-1444 PMID: 29321662
- 8. Meng H et al.. 2025. [C-X-C motif chemokine ligand 12/C-X-C motif chemokine receptor 4 regulates oxygen glucose deprivation/reoxygenation-induced autophagy in SH-SY5Y neuronal cells].. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 37(9):848-855 PMID: 41146507
